• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Stocks
American Hedge fund manager and investor Michael Burry attends the premiere of "The Big Short." Jim Spellman/Getty Images

'I am shorting the business model... I am shorting the CEO': Why two top analysts just slapped Palantir with a 'sell' rating

Wall Street tends to listen when Michael Burry (1) talks. The investor who became famous for predicting the 2008 housing collapse (he was played by Christian Bale in the 2015 Oscar-winning film, "The Big Short") dropped a bombshell ahead of Palantir Technologies (2) (NASDAQ: PLTR) first-quarter earnings this week: he was shorting the stock, the company, the CEO — all of it.

"I would argue this is not just overvaluation. I am shorting the business model. I am shorting the entire premise upon which the company rests. I am shorting the CEO," Burry wrote in a Monday Substack post (3).

Advertisement

One day later, Burry got some support from Jeffries' senior software analyst Brent Thill, who slapped Palantir with an "underweight" rating and a $70 price target (4) — implying roughly 46% downside from current levels — even after Palantir delivered 85% year-over-year revenue growth (5) in the quarter, its eleventh straight period of accelerating growth.

Burry noticed. "I saw Jefferies initiated with a price target of $70, and cited my thesis," he wrote in a Tuesday Substack post (6). "Well, the analyst did not cite me, but the words sounded familiar."

Why Jefferies says Palantir's valuation requires a 'heroic' assumption

In a CNBC interview (7) on Tuesday, Jeffries' Thill said his bearish call has nothing to do with Palantir's actual business performance. The fundamentals, he said, are "exceptional." The problem is what investors are paying for them.

Palantir's market cap sits around $330 billion. Thill estimates the company will produce roughly $12 billion in revenue next year — putting the stock at about 31 times expected 2027 revenue, according to his note. Justifying that multiple, he wrote, requires a "heroic durability assumption."

Thill compared Palantir to two other software darlings whose nosebleed multiples eventually collapsed.

"We watched Snowflake (8) at 50 times revenue go to 7. We watched Datadog (9) go from 30, 40 times to, you know, massively lower," he told CNBC. By contrast, Amazon (10) and Alphabet currently trade at roughly 12 to 18 times EBITDA — a fraction of what Palantir bulls are paying.

That valuation gap helps explain why Palantir is down about 20% year to date even as Amazon has gained 20% over the same stretch, Thill noted. "PLTR has now delivered 11 consecutive quarters of growth acceleration, which is impressive but also makes the setup increasingly difficult," he wrote in his note.

Must Read

Join 250,000+ readers and get Moneywise’s best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.

Palantir's Anthropic-sized problem

The other crack in the bull case, according to Thill, is competition — specifically a competitor that Palantir CEO Alex Karp (11) insists doesn't exist.

Advertisement

"If you look at Anthropic (12), they just raced by them," Thill said on CNBC. "If they do $12 billion next year, Anthropic's on a $40 billion run rate. You look at, and say, well, wait a minute, like, why aren't you investing in more salespeople? You're letting your margin go to 60, but there's no competition, but someone just passed you on the left side going 100 miles an hour."

That posture leaves Palantir uniquely exposed if AI enthusiasm cools. "We believe PLTR remains vulnerable to any moderation in AI enthusiasm or even modest headline deceleration," Thill wrote.

Palantir has other skeptics. Short-seller Andrew Left (13) of Citron Research and University of Florida finance professor Jay Ritter have both publicly bet against Palantir on similar valuation grounds, according to Business Insider (14).

Palantir did not immediately respond to Moneywise's request for comment about the short positions. But for all the high-profile bears, the Wall Street consensus is still very much leaning the other way. Of the roughly 30 analysts tracked by TipRanks (15), about 18 rate Palantir a "buy" and only two — Jefferies among them — call it a "sell."

The Street-high price target of $255 implies nearly 50% upside (16) from current levels. And the most aggressive bulls go even further, like Morgan Stanley's Sanjit Singh and Keith Weiss, who laid out a bull-case scenario of $382 a share (17) — more than double recent prices — arguing that "Palantir is not only delivering the best growth in public company software, but also the best profitability in all of software." Palantir's Q1 numbers seem to give those bulls only more ammunition.

Article sources

We rely only on vetted sources and credible third-party reporting. For details, see our ethics and guidelines.

Michael Burry's Substack (1),(3),(6); Palantir (2),(5),(11); Motley Fool (4),(17); CNBC (7); Snowflake Investor Relations (8); Datadog Investor Relations (9); Amazon Investor Relations (10); Anthropic (12); Citron Research (13); Business Insider (14); TipRanks (15),(16)

You May Also Like

Share this:
Dave Smith Editor-in-Chief

Dave Smith is the VP of Content at Wise Publishing and Editor-in-Chief at Moneywise and Money.ca. His work has also been published in Fortune, Business Insider, Newsweek, ABC News, and USA Today.

more from Dave Smith

Explore the latest

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither investment, tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities, enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.